|1.||Zhao, Wenpu: 1 article (12/2015)|
|2.||Hodgin, Jeffrey B: 1 article (12/2015)|
|3.||O'Dell, Alexander A: 1 article (12/2015)|
|4.||Knight, Jason S: 1 article (12/2015)|
|5.||Subramanian, Venkataraman: 1 article (12/2015)|
|6.||Kaplan, Mariana J: 1 article (12/2015)|
|7.||Smith, Carolyne K: 1 article (12/2015)|
|8.||Yalavarthi, Srilakshmi: 1 article (12/2015)|
|9.||Thompson, Paul R: 1 article (12/2015)|
|10.||Pahau, Helen: 1 article (06/2015)|
07/01/1994 - "The result that even CD4+ cells from Orx-0 mice that were thymectomized as adults and treated thereafter with DHT were effective for prevention of prostatitis suggests that activation of this Ts population takes place in the peripheral lymphoid organs, and that it maintains peripheral tolerance to autoantigen in the prostate of these mice and probably also in normal mice."
|2.||Autoimmune Diseases (Autoimmune Disease)
07/01/2006 - "Strategies to cure autoimmune disease must not only establish immunological tolerance to autoantigen, but also rid the organ of pathogenic autoreactive cells. "
12/01/2002 - "Thus, autoimmune diseases result from epigenetic changes that lead to autoantigen generation."
06/01/2000 - "Both active and passive tolerance mechanisms, therefore, contribute to autoantigen:IFA-induced protection from autoimmune disease."
04/01/1992 - "Immunointervention in autoimmune diseases from cellular selectivity to autoantigen specificity."
01/01/2004 - "Furthermore, the observation that EtxB is able to alleviate autoimmune disease in the absence of conjugation to autoantigen highlights its potential for use in the clinical setting where the target antigen is often unknown. "
|3.||Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/01/1979 - "Altered function of suppressor T lymphocytes in patients with active systemic lupus erythematosus--in vitro immune response to autoantigen."
12/01/2015 - "An imbalance between neutrophil extracellular trap (NET) formation and degradation has been described in systemic lupus erythematosus (SLE), potentially contributing to autoantigen externalisation, type I interferon synthesis and endothelial damage. "
09/15/2012 - "Our findings show that, although anergic B cells transiently acquire an activated phenotype early during infection, they do not become responsive to autoantigen, as measured by the ability to mobilize Ca2+ following AgR cross-linking or mount Ab responses following immunization. "
01/01/1990 - "In the present work we studied the influence that an infection with Toxoplasma gondii in thymus proximity produces on the suppression of autoimmune response to autoantigen of rat male accessory glands (RAG). "
01/01/2014 - "In the established KRN transgenic mouse model of rheumatoid arthritis, where IDO1 gene deletion has no effect, IDO2 deletion selectively blunts responses to autoantigen but has no effect on responses to neoantigen challenge. "
02/01/2014 - "Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis."
|4.||Monophenol Monooxygenase (Tyrosinase)
|5.||Interferon Type I
|10.||erythrocyte receptor (sialoadhesin)
|1.||Transplantation (Transplant Recipients)